日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

New Ref-1/APE1 targeted inhibitors demonstrating improved potency for clinical applications in multiple cancer types

新型 Ref-1/APE1 靶向抑制剂在多种癌症类型的临床应用中表现出更高的疗效

Silpa Gampala, Hye-Ran Moon, Randall Wireman, Jacqueline Peil, Sonia Kiran, Dana K Mitchell, Kylee Brewster, Henry Mang, Andi Masters, Christine Bach, Whitney Smith-Kinnamen, Emma H Doud, Ratan Rai, Amber L Mosley, Sara K Quinney, D Wade Clapp, Chafiq Hamdouchi, James Wikel, Chi Zhang, Bumsoo Han, M

Pharmacokinetics and Biodistribution of 16,16 dimethyl Prostaglandin E2 in Non-Irradiated and Irradiated Mice and Non-Irradiated Non-Human Primates

16,16 二甲基前列腺素 E2 在未受辐射和受辐射小鼠以及未受辐射的非人类灵长类动物中的药代动力学和生物分布

Brooke Langevin, Pratibha Singh, P Artur Plett, Carol H Sampson, Andi Masters, Allison Gibbs, Eduardo De Faria, Sarah Triesler, Andrew Zodda, Isabel L Jackson, Christie M Orschell, Mathangi Gopalakrishnan, Louis M Pelus

In Vivo Targeting Replication Protein A for Cancer Therapy

体内靶向复制蛋白 A 进行癌症治疗

Pamela S VanderVere-Carozza, Navnath S Gavande, Shadia I Jalal, Karen E Pollok, Elmira Ekinci, Joshua Heyza, Steve M Patrick, Andi Masters, John J Turchi, Katherine S Pawelczak

Improving preclinical to clinical translation in Alzheimer's disease research

改善阿尔茨海默病研究的临床前至临床转化

Stacey J Sukoff Rizzo, Andi Masters, Kristen D Onos, Sara Quinney, Michael Sasner, Adrian Oblak, Bruce T Lamb, Paul R Territo; MODEL‐AD consortium